Cost cutting is great, but the benefits have been quickly priced into the stock.
Until share value is unlocked, Cantor’s Louise Chen finds it difficult to recommend TEVA shares.
New Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) CEO Kare Schultz held his first call today to dive into the fresh restructuring strategy to …
Should you pull the trigger on Teva? Guggenheim’s Rohit Vanjani is fine staying sidelined.
This billion-dollar hedge fund initiates new position in struggling pharma TEVA as exits VRX.
Will generic Viagra turn Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares to the upside? Today, the generic drug giant announced the exclusive launch of …
Ken Griffin is a man known to be raring to take a risk when it is worthwhile, a daring and strategic mindset that …
Mizuho’s Irina Rivkind Koffler may remain apprehensive on generics competition, but the analyst likes what she sees with new plans for corporate restructuring.
Teva has stirred up Street excitement with news of executive changes and an organizational overhaul.
Here’s what Cantor’s Louise Chen has to say about the recent developments at Teva’s headquarters.
